Outlook Therapeutics, Inc. Common Stock OTLK
$0.89
-19.20%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $4.15
- Implied Upside
- +366.9%
- Price Target Range
- $1.00 – $10.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | BTIGJulian Harrison |
Reiterates | Buy | $4 |
| 2026-07-27 | HC Wainwright & Co.Douglas Tsao |
Maintains | Neutral | $1 → $2 |
| 2026-07-27 | BTIGJulian Harrison |
Upgrades | Neutral → Buy | $4 |
| 2026-06-11 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $6 → $10 |
| 2026-05-18 | BTIGJulian Harrison |
Downgrades | Buy → Neutral | — |
| 2026-03-11 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $10 → $6 |
| 2026-02-18 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Neutral | $1 |
| 2026-02-18 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $1 |
| 2026-01-05 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $3 → $1 |
| 2026-01-02 | HC Wainwright & Co.Douglas Tsao |
Maintains | Neutral | $1 → $1 |
| 2025-12-22 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $8 → $10 |
| 2025-09-30 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Neutral | $1 |
| 2025-09-22 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $21 → $8 |
| 2025-08-29 | GuggenheimEddie Hickman |
Downgrades | Buy → Neutral | — |
| 2025-08-29 | HC Wainwright & Co.Douglas Tsao |
Downgrades | Buy → Neutral | $1 |
| 2025-08-28 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $3 |
| 2025-08-15 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $3 |
| 2025-06-06 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $24 → $21 |
| 2025-02-24 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $33 → $24 |
| 2025-02-18 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $30 → $3 |
| 2025-02-18 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $3 |
| 2025-01-17 | GuggenheimEddie Hickman |
Reiterates | Buy | $12 |
| 2025-01-17 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $30 |
| 2024-12-02 | Chardan CapitalDaniil Gataulin |
Downgrades | Buy → Neutral | — |
| 2024-11-29 | BTIGJulian Harrison |
Maintains | Buy | $50 → $9 |
| 2024-11-29 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $30 |
| 2024-10-18 | BTIGJulian Harrison |
Reiterates | Buy | $50 |
| 2024-09-03 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $35 → $33 |
| 2024-08-16 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $53 |
| 2024-08-15 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.89
- Market Cap
- $205.70 million
- 52-Week Range
- $0.16 – $3.39
- Average Volume
- 14.86 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.